XML 41 R29.htm IDEA: XBRL DOCUMENT v3.22.1
FAIR VALUES OF FINANCIAL INSTRUMENTS (Tables)
12 Months Ended
Dec. 31, 2021
Fair Values Of Financial Instruments  
SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS

Assets and liabilities measured at fair value are summarized below:

 

   Total Fair Value   Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1)  

Significant Other Observable Inputs

(Level 2)

  

Significant Unobservable Inputs

(Level 3)

 
Assets:                    
                     
Recurring items as of December 31, 2021                    
Corporate debt securities, available for sale  $29,803,095   $          $   $29,803,095 
                     
Non-recurring items as of December 31, 2021                    
In-process R&D (Note 5)  $13,366,234   $   $   $13,366,234 
                     
Recurring items as of December 31, 2020                    
Corporate debt securities, available for sale  $   $   $   $ 
                     
Non-recurring items as of December 31, 2020                    
In-process R&D (Note 5)  $13,366,234   $   $   $13,366,234 
                     
Liabilities:                    
                     
Recurring items as of December 31, 2021                    
Earn-out milestone liability (Note 12)  $5,396,000   $   $   $5,396,000 
                     
Recurring items as of December 31, 2020                    
Earn-out milestone liability (Note 12)  $7,018,000   $   $   $7,017,000